Total Funding
17
60
Total FundingVenture - Series Unknown raised
Growth Score
-44 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
48602
ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury.
Stephen Badylak: Co-Founder, Chief Science Officer- Katie Collins: Co-Founder, VP Business Development
About the Company
ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury. The company also develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM). It provides cues for cell attachment, migration, proliferation, and 3-D
spatial organization.
ECM Therapeutics' patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. It utilizes the body’s own template to restore naturally occurring functional tissue following injury.
ECM Therapeutics was founded in 2018 and is based in Warrendale, Pennsylvania, United States.
Women Founded
